A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Breast Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Avera Cancer Institute - Marshall, Marshall, Minnesota, United States

  • Avera Cancer Institute - Aberdeen, Aberdeen, South Dakota, United States

  • Avera Cancer Institute - Mitchell, Mitchell, South Dakota, United States

  • Avera Cancer Institute - Pierre, SD, Pierre, South Dakota, United States

  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

  • AMG Oncology and Hematology Avera Cancer Institute - Yankton, Yankton, South Dakota, United States

  • Inst. Alexander Fleming, Buenos Aires, Argentina

  • Centro Oncologico Korben, Caba, Argentina

  • Centro Médico Fleischer, Capital Federal, Argentina

  • Sanatorio de la Mujer, Rosario, Argentina

  • Hospital Santa Rita de Cassia Vitoria, Vitória, Espírito Santo, Brazil

  • Hospital Brasilia, Brasília, Federal District, Brazil

  • ICTR Curitiba, Curitiba, Paraná, Brazil

  • Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo, São Paulo, Brazil

  • CIUSSS du Saguenay Lac-Saint-Jean, Chicoutimi Hospital, Chicoutimi, Quebec, Canada

  • McGill University, Montreal, Quebec, Canada

  • Centre Oscar Lambret, Lille, France

  • Centre Leon Berard, Lyon, France

  • Institut Paoli Calmettes, Marseille, France

  • Institut Régional du Cancer de Montpellier, Montpellier, France

  • Institut Universitaire du Cancer - Oncopole Toulouse (IUCT-O), Toulouse, France

  • Uniklinik RWTH Aachen Klinik für Gynäkologie und Geburtsmedizin, Aachen, Germany

  • Universitätsklinik Tübingen, Tübingen, Germany

  • Istituto Nazionale Tumori Irccs Fondazione g. PASCALE, Naples, Campania, Italy

  • IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola, Emilia-Romagna, Italy

  • Università Campus Bio-Medico di Roma, Rome, Lazio, Italy

  • Asst Papa Giovanni XXIII, Bergamo, Lombardy, Italy

  • Ospedale San Raffaele, Milan, Lombardy, Italy

  • Irccs Istituto Nazionale Dei Tumori (Int), Milan, Lombardy, Italy

  • Instituto Nacional De Cancerologia, Distrito Federal, Mexico CITY (federal District), Mexico

  • Centro de Investigacion Clinica de Oaxaca, Oaxaca City, Oaxaca, Mexico

  • Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico

  • Instytut "Centrum Zdrowia Matki Polki", ?ód?, Poland

  • Bialostockie Centrum Onkologii, Bialystok, Poland

  • COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej, Lublin, Poland

  • Dolno?l?skie Centrum Onkologii, Wroc?aw, Poland

  • Soon Chun Hyang University Cheonan Hospital, Dongnam-gu, Cheonan-si, South Korea

  • Gachon University Gil Medical Center, Namdong-Gu, South Korea

  • Seoul National University Bundang Hospital, Seongnam-si, South Korea

  • Seoul National University Hospital, Seoul, South Korea

  • ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Hospital Universitario Clínico San Cecilio, Granada, Spain

  • Hospital Ramon y Cajal, Madrid, Spain

  • Hospital Universitario 12 de Octubre, Madrid, Spain

  • Hospital Clinico Universitario de Valencia, Valencia, Spain

  • Leicester Royal Infirmary, Leicester, United Kingdom

  • Royal Free Hospital, London, United Kingdom

  • Christie Hospital Nhs Trust, Manchester, United Kingdom

מובילי המחקר
  • Clinical Trials

    Study Director

    Hoffmann-La Roche